Sort
261,768 grants matching “gene therapy”
Molecular Biology and Genetics of Human Tumor Viruses
$1,858,213William M. Sugden · University Of Wisconsin-Madison · P01 · FY2011 · CA
RNAi and Epigenetic Control of Higher-Order Chromatin Assembly
$1,858,210Shivinder S Grewal · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome
$1,858,210Shivinder S Grewal · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Gene Therapy for Hemophilia
$1,857,933Katherine A High · Children'S Hosp Of Philadelphia · P01 · FY2007 · HL
Signaling to and from the Synapse
$1,857,751Richard L Huganir · Johns Hopkins University · P50 · FY2010 · MH
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
$1,857,725Estuardo Aguilar-Cordova · Advantagene, Inc · R44 · FY2013 · CA
Biology and Transplantation of the Hematopoietic Stem Cell
$1,857,651John E Wagner · University Of Minnesota · P01 · FY2019 · CA
Molecular Genetics Support to Identify Gene/Environment Interactions in Disease
$1,857,305Lutz Birnbaumer · National Institute Of Environmental Health Sciences · ZIC · FY2010 · ES
Gene Therapy Pulmonary &Hematologic Disorders
$1,857,226University Of North Carolina Chapel Hill · P01 · FY2003 · HL
Recombinant Adeno Associated Virus Vectors for Gene Transfer
$1,856,892Robert Kotin · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Polymerase theta, genome instability, and cancer
$1,856,436Dale A Ramsden · Univ Of North Carolina Chapel Hill · P01 · FY2020 · CA
Establishment of a SPF Rhesus Macaque Colony
$1,856,331Robert E Lanford · Texas Biomedical Research Institute · U42 · FY2015 · OD
Restoration of proteostasis to address co-occurring conditions in Down Syndrome
$1,856,328Nirinjini N Naidoo · University Of Pennsylvania · RF1 · FY2022 · AG
Autonomic Cardiovascular Regulation
$1,856,319Vanderbilt University · P01 · FY2003 · HL
The role of the macroenvironment in pancreatic cancer-induced cachexia
$1,855,958Denis C Guttridge · Medical University Of South Carolina · P01 · FY2025 · CA
CHILDHOOD ASTHMA: EARLY PREVENTION AND PHARMACOGENETICS
$1,855,895University Of Arizona · U10 · FY2003 · HL
Rescuing the Fragile X Syndrome by Resetting Translational Homeostasis
$1,855,247Joel D Richter · Univ Of Massachusetts Med Sch Worcester · U54 · FY2015 · HD
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancers
$1,855,117Charles David Allis · Rockefeller University · P01 · FY2016 · CA
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancers
$1,855,117Charles David Allis · Rockefeller University · P01 · FY2017 · CA
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancers
$1,855,117Charles David Allis · Rockefeller University · P01 · FY2018 · CA
Etiology of Alkylator-Induced Myeloid Leukemia
$1,854,803Michelle M Le Beau · University Of Chicago · P01 · FY2012 · CA
DNA virus as vectors for cardiovascular diseases
$1,854,749James M Wilson · University Of Pennsylvania · P01 · FY2009 · HL
Induction of Donor Tolerance in Renal Transplants
$1,854,655Suzanne T Ildstad · Regenerex, Llc · R42 · FY2011 · DK
Center for Cancer Nanotechnology Excellence for Translational Diagnostics (CCNE-TD)
$1,854,519Sanjiv S Gambhir · Stanford University · U54 · FY2015 · CA
A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis
$1,854,342Nuria Tubau Juni · Biotherapeutics, Inc. · R44 · FY2025 · AR